KATHRYN ALDER: Open Payments
NPI 1235648858 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,718 in 185 payments from 21 companies in 2025. Trend: 2023 $2,050 · 2024 $3,464 · 2025 $3,718
Food & beverage: $3,708Education: $10
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 50 | $557 |
| Janssen Biotech, Inc. | 23 | $525 |
| ABBVIE INC. | 27 | $412 |
| Madrigal Pharmaceuticals | 7 | $349 |
| GENZYME CORPORATION | 8 | $275 |
| PFIZER INC. | 10 | $184 |
| QOL Medical, LLC | 9 | $181 |
| Ardelyx, Inc. | 7 | $179 |
| Ipsen Biopharmaceuticals, Inc | 9 | $157 |
| Phathom Pharmaceuticals, Inc. | 3 | $152 |
Products named: XIFAXAN, TREMFYA, DUPIXENT, REZDIFFRA, RINVOQ, Sucraid, IBSRELA, IQIRVO.
Industry payments across NY — which companies pay providers there.
